tiprankstipranks
pc:inf2p

Infinitopes

Infinitopes is a clinical-stage cancer vaccine biotechnology company developing AI/ML-driven precision therapeutic vaccines to prevent cancer recurrence. The company combines precision target discovery and high-efficiency vector delivery platforms to create immunologically durable vaccines for multiple solid tumour indications and is supported by Cancer Research UK and the University of Oxford.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$35M
Total Amount Raised$35M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$35M
Latest Funding Amount$35M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 21, 2026
Seed Round
$35.10M

Investors

Investor Name
Funding Round

Related News and Analysis